The short version
- Why people research itSynaptogenesis for memory and cognition (potent HGF/c-Met pathway).
- What the evidence isNo human trials: development stopped at preclinical, so the ceiling on any claim here is a rodent model — and these transfer poorly.
- What to watchA lump or lesion that grows.
How Dihexa works
Angiotensin-IV analog that potentiates HGF/c-Met signaling to drive synaptogenesis — potent nootropic/neuro-repair.
The sequence is the page, and once you read it properly the compound stops being a peptide. Angiotensin IV is the hexapeptide Val-Tyr-Ile-His-Pro-Phe, the 3–8 fragment of angiotensin II.
Count what is left. Of the original six residues, exactly two survive: Tyr-Ile. The hexanoyl group capping the amino end and the 6-aminohexanoic amide capping the carboxyl end are not amino acids at all — they are fatty-acid-like spacers.
- Oral
- Nasal
On the goal map: Glutamatergic & synaptic plasticity (Focus, memory & cognition)
Research on Dihexa1 cited paper retracted (Benoist 2014); 4 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
- Benoist CC 2014, The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system, J Pharmacol Exp Ther: PMID 25187433 RETRACTED by the journal, April 2025, PMID 40312093 (retraction notice)
Human clinical evidence
No human trials: development stopped at preclinical, so the ceiling on any claim here is a rodent model — and these transfer poorly.
No completed human trial
Correlative data
Small community use, mostly for cognitive recovery. The safety record is community reports only, and for a compound this potent at promoting synapse formation that gap is worth taking seriously rather than waving through.
How the mechanism reads
An angiotensin IV analog that potentiates hepatocyte growth factor signaling through the c-Met receptor. Rodent work reports it is orders of magnitude more potent than BDNF at promoting synaptogenesis, with cognitive restoration in lesion models.
Experimental, animal or cellc-Met is also an oncogene, amplified in several cancers. A compound whose mechanism is potent growth-factor receptor activation carries exactly the proliferation question that BPC-157 and the IGF analogs do, and here it is aimed at the brain.
Mechanistic
Sources
- McCoy AT. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. J Pharmacol Exp Ther 2013 · PMID 23055539
- Benoist CC. The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system. J Pharmacol Exp Ther 2014 · PMID 25187433 (RETRACTED by the journal, April 2025, PMID 40312093)
- Uribe PM. Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure. Front Cell Neurosci 2015 · PMID 25674052
- Hallberg M, Larhed M. From Angiotensin IV to Small Peptidemimetics Inhibiting Insulin-Regulated Aminopeptidase. Front Pharmacol 2020 · PMID 33178027
- Wright JW. The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases. Prog Neurobiol 2015 · PMID 25455861
Dihexa safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Cancer or precancerous lesions, since HGF and c-Met signaling drives tumor growth and spread.
- A family history of cancers in which c-Met is active, such as prostate or lung.
- Pregnancy or breastfeeding, since HGF signaling is central to fetal organ growth.
- Under 18, where nothing is known about c-Met activation in the developing brain.
What’s expected
- No human effect has ever been measured.
- Rodent work shows synaptogenesis and memory gains at very low exposure.
- Cancer-signal concerns come from the receptor biology, not from a trial.
Watch for
- A lump or lesion that grows.
- New persistent cough or unexplained weight loss.
- Severe headaches.
Labs that tell you it’s working
- PSA Total + Free + % Free: prostate tissue is a c-Met-active site worth tracking in men.
- Comprehensive Metabolic Panel: baseline liver and kidney for a molecule with no human exposure.
- hs-CRP: a general inflammatory read.
Angiotensin IV analog that potentiates HGF/c-Met to drive synaptogenesis; harm prediction rests on the oncogenic potential of c-Met activation. PMID 23055539 PMID 25187433 (RETRACTED by the journal, April 2025, PMID 40312093) PMID 33178027
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Dihexa FAQ4 common questions
- Is Dihexa approved for human use?
- No. Dihexa is a research compound. No completed randomized human trial has given it yet.
- What is Dihexa researched for?
- Synaptogenesis for memory and cognition (potent HGF/c-Met pathway).
- Which labs show whether it's doing anything?
- PSA Total + Free + % Free; Comprehensive Metabolic Panel; hs-CRP: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Dihexa: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.





